Even though they were mentally prepared, the child's parents couldn't help but look pale when they heard this.
"Is there really no other way?" Lila asked.
Coincidentally, this expert happened to be the head of a rare disease laboratory funded by Lila's foundation, and he had known Lila before.
The other party sighed: "The development of drugs for rare diseases is inherently difficult, and there are few people doing it. The same is true for gene-related diseases. Currently, progress in this area is relatively slow, both at home and abroad."
Lila turned her head to look at the family of three. The couple were in a daze. The pain was like a chronic poison, eroding their bodies bit by bit.
Login to comment
Be the first one to comment...